Skip to main content
Daito Pharmaceutical Co., Ltd. logo

Daito Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 4577 ISIN · JP3486150000 T Manufacturing
Open in API
Filings indexed 79 across all filing types
Latest filing 2026-06-11 Transaction in Own Shar…
Country JP Japan
Listing T 4577

About Daito Pharmaceutical Co., Ltd.

https://www.eng.daitonet.co.jp/

Daito Pharmaceutical Co., Ltd. is a manufacturer specializing in the integrated production of pharmaceuticals, from active pharmaceutical ingredients (APIs) to finished formulation products. The company's core activities include the development and supply of APIs, primarily for generic drugs, and the manufacturing of generic and over-the-counter (OTC) medications. Additionally, Daito provides contract manufacturing services for various pharmaceutical products. The company emphasizes a comprehensive quality assurance system to ensure the stable supply of high-quality products to its clients.

Recent filings

Filing Released Lang Actions
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 90% confidence The document is a “自己株券買付状況報告書” filed under the Financial Instruments and Exchange Act, detailing the company’s treasury stock (own shares) acquisition and disposal numbers and amounts over a reporting period. This matches the “Transaction in Own Shares” category (POS), which covers share repurchases/issuances.
2026-06-11 Japanese
Notice Regarding the Completion of Cancellation of Treasury Shares
Share Issue/Capital Change Classification · 87% confidence The document is a corporate announcement that Daito Pharmaceutical completed the cancellation of treasury shares (i.e., a reduction in share capital following share repurchase). This is not a full financial report, AGM material, or director dealing but rather a notice of a capital change (cancellation of shares). Accordingly, it falls under the Share Issue/Capital Change category (SHA).
2026-06-01 English
自己株式の消却完了に関するお知らせ
Transaction in Own Shares Classification · 92% confidence The document is a formal announcement by a Japanese company regarding the completion of cancellation (‘消却’) of treasury shares under Company Law Article 178. It details the number of shares cancelled, the date of cancellation, and post-cancellation totals. This constitutes a report of the company’s transaction in its own shares (cancellation of treasury stock). Thus it fits the Transaction in Own Shares category.
2026-06-01 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 98% confidence The document is a statutory report filed under the Financial Instruments and Exchange Act (Art. 24-6-1) detailing the company’s own‐share repurchase activity (dates, quantities, amounts). It is not a simple announcement but the actual regulatory purchase report. This matches the “Transaction in Own Shares” category (POS).
2026-05-12 Japanese
ダイトが他2社と設立予定の共同出資会社による杏林製薬の後発医薬品事業の承継に関する基本合意書の締結について
Regulatory Filings
2026-04-24 Japanese
自己株式の取得状況及び取得終了に関するお知らせ
Regulatory Filings
2026-04-22 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.